OMEROS CORP (OMER) Current Ratio
- Current ratio · latest quarter: Value 1.95×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.95× | Current assets / current liabilities. $185.24M ÷ $94.96M ≈ 1.95× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 185.24M USD | Assets, Current |
| Current obligations | 94.96M USD | Liabilities, Current |
| Cash and equivalents | 1.99M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 11.71M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 842.00K USD | Inventory, Net |
| Payables | 6.34M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $185.24M | $94.96M | $1.99M | (m) | $11.71M | $842.00K | $6.34M | (m) | 1.95× |
| 2026-03-31 | $180.35M | $59.44M | $1.91M | (m) | $6.75M | $183.00K | $5.37M | (m) | 3.03× |
| 2025-12-31 | $215.67M | $78.06M | $9.66M | (m) | $0.00 | $0.00 | $4.76M | (m) | 2.76× |
| 2025-09-30 | $71.81M | $80.76M | $2.40M | (m) | (m) | (m) | $12.50M | (m) | 0.89× |
| 2025-06-30 | $69.65M | $85.50M | $1.90M | (m) | (m) | (m) | $8.84M | (m) | 0.81× |
| 2025-03-31 | $96.18M | $83.22M | $4.26M | (m) | (m) | (m) | $4.41M | (m) | 1.16× |
| 2024-12-31 | $134.12M | $79.53M | $3.40M | (m) | (m) | (m) | $5.91M | (m) | 1.69× |
| 2024-09-30 | $164.92M | $55.62M | $1.52M | $121.64M | (m) | (m) | $7.72M | (m) | 2.96× |
| 2024-06-30 | $202.93M | $59.48M | $2.12M | $156.79M | (m) | (m) | $6.50M | (m) | 3.41× |
| 2024-03-31 | $280.96M | $59.06M | $1.83M | $228.48M | (m) | (m) | $6.18M | (m) | 4.76× |
| 2023-12-31 | $217.90M | $53.32M | $7.11M | (m) | (m) | (m) | $7.71M | (m) | 4.09× |
| 2023-09-30 | $351.34M | $147.18M | $30.64M | $279.67M | (m) | (m) | $5.87M | (m) | 2.39× |
| 2023-06-30 | $388.56M | $143.54M | $6.60M | $334.59M | (m) | (m) | $9.55M | (m) | 2.71× |
| 2023-03-31 | $417.04M | $139.19M | $3.83M | $367.73M | (m) | (m) | $6.45M | (m) | 3.00× |
| 2022-12-31 | $443.24M | $136.38M | $11.01M | $183.93M | (m) | (m) | $5.99M | (m) | 3.25× |
| 2022-09-30 | $288.55M | $39.51M | $145.53M | (m) | (m) | (m) | $17.09M | (m) | 7.30× |
| 2022-06-30 | $192.72M | $38.50M | $14.14M | (m) | (m) | (m) | $10.88M | (m) | 5.01× |
| 2022-03-31 | $210.22M | $35.07M | $8.96M | (m) | (m) | (m) | $7.34M | (m) | 6.00× |
| 2021-12-31 | $247.96M | $51.79M | $100.81M | (m) | (m) | (m) | $13.40M | (m) | 4.79× |
| 2021-09-30 | $91.35M | $42.82M | $7.42M | (m) | (m) | $712.00K | $10.03M | (m) | 2.13× |
| 2021-06-30 | $112.40M | $47.70M | $12.70M | (m) | (m) | $978.00K | $9.50M | (m) | 2.36× |
| 2021-03-31 | $132.48M | $43.43M | $9.03M | (m) | (m) | $1.19M | $11.50M | (m) | 3.05× |
| 2020-12-31 | $151.28M | $36.74M | $10.50M | (m) | (m) | (m) | $4.20M | (m) | 4.12× |
| 2020-09-30 | $195.99M | $47.72M | $21.07M | (m) | (m) | $1.54M | $7.02M | (m) | 4.11× |
| 2020-06-30 | $38.93M | $38.05M | $1.96M | (m) | (m) | $1.89M | $8.51M | (m) | 1.02× |
| 2020-03-31 | $85.61M | $57.94M | $7.12M | (m) | (m) | $1.21M | $12.96M | (m) | 1.48× |
| 2019-12-31 | $103.75M | $55.46M | $3.08M | (m) | (m) | $1.15M | $5.33M | (m) | 1.87× |
| 2019-09-30 | $63.80M | $46.75M | $8.86M | (m) | (m) | $1.17M | $9.70M | (m) | 1.36× |
| 2019-06-30 | $65.94M | $40.67M | $3.99M | (m) | (m) | $1.19M | $6.26M | (m) | 1.62× |
| 2019-03-31 | $76.87M | $44.51M | $4.05M | (m) | (m) | $736.00K | $7.12M | $2.56M | 1.73× |
| 2018-12-31 | $89.87M | $37.36M | $5.86M | (m) | (m) | $88.00K | $6.28M | (m) | 2.41× |
| 2018-09-30 | $66.00M | $24.59M | $2.79M | (m) | (m) | $214.00K | $8.85M | $560.00K | 2.68× |
| 2018-06-30 | $96.50M | $24.44M | $2.88M | (m) | (m) | $235.00K | $11.85M | $608.00K | 3.95× |
| 2018-03-31 | $78.68M | $24.63M | $1.19M | (m) | (m) | $247.00K | $10.18M | $513.00K | 3.19× |
| 2017-12-31 | $108.37M | $26.31M | $3.39M | (m) | (m) | $443.00K | $6.69M | $490.00K | 4.12× |
| 2017-09-30 | $117.90M | $24.69M | $1.03M | (m) | (m) | $822.00K | $3.68M | $368.00K | 4.78× |
| 2017-06-30 | $53.09M | $24.75M | $3.39M | (m) | (m) | $905.00K | $2.57M | $250.00K | 2.14× |
| 2017-03-31 | $51.35M | $16.97M | $1.28M | (m) | (m) | $960.00K | $2.41M | $228.00K | 3.03× |
| 2016-12-31 | $60.26M | $16.07M | $2.22M | (m) | (m) | $1.13M | $2.52M | $198.00K | 3.75× |
| 2016-09-30 | $60.65M | $16.06M | $10.30M | (m) | (m) | $1.40M | $3.98M | $190.00K | 3.78× |
| 2016-06-30 | $34.10M | $16.07M | $4.59M | (m) | (m) | $1.78M | $5.42M | $193.00K | 2.12× |
| 2016-03-31 | $24.32M | $17.52M | $978.00K | (m) | (m) | $1.97M | $5.33M | $69.00K | 1.39× |
| 2015-12-31 | $37.15M | $16.25M | $1.36M | (m) | (m) | $472.00K | $6.43M | $73.00K | 2.29× |
| 2015-09-30 | $39.46M | $22.27M | $601.00K | (m) | (m) | $445.00K | $4.58M | $9.58M | 1.77× |
| 2015-06-30 | $56.68M | $20.10M | $2.56M | (m) | (m) | $633.00K | $4.04M | $9.29M | 2.82× |
| 2015-03-31 | $73.07M | $20.07M | $1.44M | (m) | (m) | $566.00K | $4.61M | $9.02M | 3.64× |
| 2014-12-31 | $9.04M | $18.32M | $354.00K | (m) | (m) | $568.00K | $4.92M | $6.33M | 0.49× |
| 2014-09-30 | $23.36M | $14.40M | $750.00K | (m) | (m) | (m) | $4.16M | $3.99M | 1.62× |
| 2014-06-30 | $38.97M | $12.17M | $1.53M | (m) | (m) | (m) | $5.08M | $1.61M | 3.20× |
| 2014-03-31 | $54.13M | $10.23M | $567.00K | (m) | (m) | (m) | $4.93M | $0.00 | 5.29× |
| 2013-12-31 | $14.82M | $11.87M | $1.38M | (m) | (m) | $0.00 | $2.33M | $5.60M | 1.25× |
| 2013-09-30 | $10.27M | $11.90M | $1.15M | (m) | (m) | (m) | $3.36M | $4.02M | 0.86× |
| 2013-06-30 | $21.27M | $10.90M | $1.72M | (m) | (m) | (m) | $4.25M | $2.48M | 1.95× |
| 2013-03-31 | $15.81M | $10.59M | $1.28M | (m) | (m) | (m) | $2.61M | $997.00K | 1.49× |
| 2012-12-31 | $24.70M | $8.36M | $1.52M | (m) | (m) | (m) | $2.63M | $0.00 | 2.95× |
| 2012-09-30 | $31.44M | $21.81M | $1.06M | (m) | (m) | (m) | $2.70M | (m) | 1.44× |
| 2012-06-30 | $8.52M | $17.25M | $7.27M | (m) | (m) | (m) | $1.28M | (m) | 0.49× |
| 2012-03-31 | $19.70M | $18.74M | $16.80M | (m) | (m) | (m) | $2.39M | (m) | 1.05× |
| 2011-12-31 | $25.95M | $18.98M | $4.00M | (m) | (m) | (m) | $2.00M | $5.89M | 1.37× |
| 2011-09-30 | $33.84M | $15.81M | $4.89M | (m) | (m) | (m) | $1.65M | (m) | 2.14× |
| 2011-06-30 | $39.67M | $14.34M | $4.16M | (m) | (m) | (m) | $814.00K | (m) | 2.77× |
| 2010-12-31 | $43.75M | $15.37M | $3.28M | (m) | (m) | (m) | $2.40M | (m) | 2.85× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |